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Abstract 
Maternal immunization is an important strategy to prevent severe morbidity and mortality in 
mothers and their offspring. This study aimed to identify whether new parents were following 
immunization recommendations prior to pregnancy, during pregnancy, and postnatally. A 
cross-sectional survey was conducted by a questionnaire administered antenatally to pregnant 
women attending a maternity hospital with a follow-up telephone interview at 8-10 weeks 
post-delivery. Factors associated with uptake of pertussis vaccination within the previous five 





































binomial regression models. A total of 297 pregnant women completed the questionnaire.  For 
influenza vaccine, 20.3% were immunized during pregnancy and 3.0% postnatally. For 
pertussis vaccine, 13.1% were vaccinated within five years prior to pregnancy and 31 women 
received the vaccine postnatally, 16 (51.6%) received the vaccine > 4 weeks after delivery. 
Receiving a recommendation from a healthcare practitioner (HCP) was an independent 
predictor for receipt of both pertussis (RR 2.07, p<0.001) and influenza vaccine (RR 2.26, 
p=0.001). Non-English speaking mothers were significantly less likely to have received 
pertussis vaccination prior to pregnancy or postnatally (RR 0.24, p=0.011). Multiparous 
pregnant women were less likely to have received an influenza vaccine during their current 
pregnancy (p=0.015). Uptake of pregnancy related immunization is low and likely due to poor 
knowledge of availability, language barriers and lack of recommendations from HCPs. 
Strategies to improve maternal vaccine uptake should include education about recommended 
vaccines for both HCPs and parents and written information in a variety of languages. 
Abbreviations 
ABS – Australian Bureau of Statistics 
HCP - Health Care Provider  
MMR - measles, mumps, rubella  
USA – United States of America 
UK – United Kingdom 






































To reduce the morbidity and mortality from infectious diseases in pregnant women and their 
newborns, many countries recommend influenza immunization during pregnancy and 
pertussis immunization prior to pregnancy as part of pregnancy planning.1,2 In Australia, the 
National Health and Medical Research Council guidelines recommend that a pre-conception 
health check should include assessment of measles, mumps, rubella (MMR), varicella, 
diphtheria, tetanus and pertussis immunization status.
1
 
The majority of hospitalisations and deaths from pertussis occur in infants less than six 
months of age as they have not received a complete course of pertussis immunization 3-5 and 
infection mainly occurs via transmission from parents with waning vaccine-induced 
immunity.
6-8
 Based on this evidence, it is recommended that potential parents and other adults 
within the same household receive a pertussis containing vaccine if not received in the 
preceding five years as part of a “cocooning” strategy. In response to previous pertussis 
epidemics, authorities in the United States of America (USA), the United Kingdom (UK), 
New Zealand and Australia now recommend pertussis immunization in the third trimester of 
pregnancy to protect newborns.
9-11
 
Pregnant women are also at increased risk of severe illness, hospitalization and death from 
influenza, particularly evident during the H1N109 Influenza Pandemic.
12-14
  Influenza 
immunization has been recommended as the most effective way of preventing hospitalizations 
and severe influenza-related complications in pregnant women and their infants to six months 
of age.
15-18
 In Australia, seasonal influenza vaccine is available from March to October each 
year during the peak influenza season and is generally provided by family physicians. 
This study aimed to determine whether parents were following the current immunization 





































determine the proportion of pregnant women who had received a pertussis vaccine as part of 
the cocooning strategy, and/or influenza vaccine during pregnancy. We also sought to 
determine facilitators and barriers to uptake of maternal immunizations. 
Results 
1. Survey population and response rate 
Of 465 pregnant women approached in the antenatal public and private obstetric clinics from 
December 2010-August 2011, 300 (64.5%) enrolled in the study and 297 completed the 
questionnaire (Figure 1). Women were asked if they were interested in participating in a 
research study on immunisation. Postnatal follow-up telephone calls were completed for 272 
(91.6%) enrolled participants. 
The mean age of participants was 30.4 years (range 17-44 years). The majority of respondents 
were Caucasian (86.9%; n=258) with 10.1% (n=30) of Asian ethnicity.  The majority of 
participants were born in Australia (73.7%, n=219), married (61.6%, n=183) and almost half 
had no previous children (46.8%, n=139) (Table 1). These sample characteristics are similar 
to South Australian or Australian population characteristics for pregnant women according to 
the 2013 Australian Bureau of Statistics (ABS) data.19 The ABS data indicates the median age 
for South Australian pregnant women as 30.4 years and the proportion of South Australian 
pregnant women who were married as 63.9%.  Country of Mothers birth was also similar 
between our sample and Australian ABS data with Australia as the predominant birth country 
of new mothers (73.7% vs 67.5%). The proportion of pregnant women with no previous 
children was also similar between our cohort (46.8%) and ABS data for Australian (44.7%). 






































A total of 67 women (22.6%) had received pertussis vaccination within the previous five 
years (n=39) or following birth (n=31).  Three of these participants received both pertussis 
vaccine prior to pregnancy and postnatally. 
Whilst 43.1% (n=128) of respondents reported having received a pertussis (whooping cough) 
vaccine during their lifetime, only 1.3% (n=4) received the immunization as part of their 
pregnancy planning. Almost a quarter (24.2%, n=72) of participants were unsure whether they 
had previously received a “whooping cough” vaccine. Of the 128 women who reported 
receiving pertussis vaccination, 12.5% (n=16) had done so within the preceding 12 months 
and a further 18.0% (n=23) had been immunized between 12 months and five years prior. The 
remaining 64.1% (n=82) received their last pertussis vaccine more than five years previously 
and 5.6% (n=7) could not remember when it had been administered. 
Factors associated with receiving pertussis vaccination prior to pregnancy or postnatally, were 
explored. Knowledge of pertussis vaccine availability prior to the study, a recommendation 
from a HCP, English as first language, age greater than 30 years and higher level of education 
were univariate predictors of having received pertussis vaccination. English as a first 
language and recommendation from a HCP remained significantly associated with uptake in a 
multiple log binomial regression analysis. Women who had English as a second language 
were almost five times less likely (RR 0.24, p=0.011) to have received a pertussis vaccination 
within the previous five years or postnatally (Table 2).  
2.2 Influenza  
Of 237 mothers whose influenza vaccination status was able to be determined, only 48 
women (20.3%) received the influenza vaccine during their pregnancy, and an additional 
seven mothers (3.0%) received the vaccine postnatally.  In a multiple regression analysis, 





































pregnancy compared with nulliparous women (p=0.017). Women who had received a 
recommendation to receive an influenza vaccine from a HCP were 2.26 times more likely to 
have received the vaccine during pregnancy than those who had not received a 
recommendation (p=0.001).  Women who were aware of the availability of influenza 
vaccination during pregnancy prior to study participation were 3.14 times more likely to be 
vaccinated (p=0.026) (Table 3). 
A total of 51.5% (n=153) of mothers reported having received the influenza vaccine during 
their lifetime. Of these 153 individuals, 46.4% (n=71) had received their last influenza 
vaccine in the preceding 12 months, with 41.2% (n=63) having received it between 12 months 
and 5 years prior and 12.4% (n=19) having received an influenza vaccine more than five years 
prior. 
3. Parents’ knowledge of vaccine preventable diseases and corresponding immunizations 
3.1 Pertussis (whooping cough) 
Almost all respondents (95.0%, n=282) indicated they had heard of whooping cough although 
only a minority of pregnant women (37.7%, n=112) were aware that a pertussis vaccine was 
available prior to pregnancy or postnatally. Their source/s (multiple responses) of information 
included various HCPs (41.1%, n=46; midwives and obstetricians (n= 19), family physicians 
(n=27)), family/or friends (n=24) and media (n=18). 
3.2 Influenza 
The majority (70.0%, n=208) of respondents were aware that influenza vaccine was available 
prior to, or during pregnancy. Almost half of these respondents (45.7%; n=95) reported the 
source of information about influenza vaccine was their HCP.  Other sources reported 
included media (n=40), workplace (n=23), family and friends (n=22), posters and leaflets 





































Less than a quarter of respondents (21.9%, n=65) had received a recommendation from a 
HCP to receive an influenza vaccine prior to conception or during pregnancy.  The majority 
of these recommendations came from family physicians (90.8%, n=59), with 
recommendations also reported from midwives (n=4), a travel doctor (n=1) and an 
obstetrician (n=1). 
4. Uptake of vaccines in the postpartum period 
A total of 272 follow-up phone calls were completed. Of these, a total of 15.4% (n=42) 
respondents indicated they had received one or more vaccines postnatally, including pertussis 
vaccine (n=31), both influenza and pertussis (n=5), influenza alone (n=2) or both varicella 
and pertussis (n=1). Pertussis immunization was confirmed either by date of administration or 
with the immunization provider for all 31 mothers. Furthermore, 12.7% (n=35) of women 
reported their partner had received a pertussis vaccine.  Three mothers received the vaccine 
within the first week after delivery with the remaining mothers being immunized between 8- 
90 days post-delivery (median 38 days post-delivery). The most common reason cited for 
receiving a pertussis vaccine was for newborn protection (36.6%), with 33.3% of respondents 
receiving a recommendation from HCPs and 16.6% from family and friends.  Three mothers 
stated their decision had been influenced by participation in the study and three were 
influenced by knowledge of the pertussis epidemic. 
Of those who had not received a pertussis or influenza vaccine since the birth of their baby 
and were contactable (n=230), commonly cited reasons were that vaccine/s were not offered 
or discussed, or they had no awareness of their need for immunization (30.9%, n=71), a belief 
that immunization so soon after delivery was unnecessary (17.8%, n=41), being time poor 
after delivery (17.4%, n=40) or simply forgetting (13.5%, n=31) (Table 4).  





































A total of 73.4% (n=218) of respondents indicated they would have received a pertussis 
vaccine prior to pregnancy had it been recommended to them. During antenatal care, only 
16.2% (n=48) had received a recommendation to receive pertussis vaccine postnatally.  Of the 
258 women who had not received a pertussis vaccine within the previous five years, 60.9% 
(n=157) had intended to receive the pertussis vaccine after their baby was born, 28.7% (n=74) 
were undecided and 9.3% (n=24) had never intended to have the vaccine. One hundred and 
fifty-four (59.7%) participants reported they would have received it had it been 
recommended, while 16.3% (n= 42) were undecided.   
For the 226 women who had not received an influenza vaccine in the previous 12 months, 120 
(53.1%) stated they would have received an influenza vaccine had it been recommended, and 
a further 41 (18.1%) were undecided. 
6. Identifying concerns/barriers for maternal immunization 
Over a third (35.1%, n=104) of respondents indicated they had concerns about receiving a 
booster pertussis vaccine. The most common concerns were of potential side-effects of the 
vaccine to themselves (22.6%, n=67) or their infants through breast feeding (12.2%, n=36) or 
ineffectiveness of the vaccine (16.2%, n=48). A minority indicated cost as a concerning factor 
(3.4%, n=10) or disliked injections (5.7%, n=17). .  
Over half of the women surveyed (54.2%, n=161) indicated they had concerns about having 
any vaccine whilst pregnant. The most commonly reported concerns were potential side 
effects to themselves 46.7% (n=134) or their unborn baby 40.1% (n=115).  Cost was a 
reported concern for 4.5% (n=13) and 4.2% (n=12) disliked injections. .  
Comment 
Our results show low uptake of all recommended immunizations related to pregnancy, 





































the recommendation for influenza vaccine during pregnancy, of those who had not received it 
as part of pregnancy planning, the majority of women agreed they would have received the 
vaccine had it been recommended to them. Many respondents had concerns about potential 
side effects for themselves and/or their unborn child, and therefore avoided immunization 
during pregnancy.  
In this study, a recommendation to receive vaccines provided greater likelihood of 
immunisation. This emphasises the importance of knowledge provision from HCPs to 
improve immunization uptake for pregnant women and their partners when planning a 
pregnancy, with appropriate educational materials provided to HCPs to ensure they are aware 
of the current recommendations and reasons influencing decision making by parents/ mothers. 
Women with English as a second language and lower educational levels were less likely to 
have received influenza or pertussis vaccinations. This suggests that current available 
information may be insufficient or inaccessible to these groups. Educational materials that are 
sensitive to ethnic diversity, easily readable and accessible to all new parents should be a 
priority for policy makers.  
At the time of this study, cocooning was the only recommended strategy in Australia to 
provide protection to unimmunized  or partly immunized  infants.  A recent study has shown 
evidence that pertussis immunization prior to conception or within 4 weeks after birth was 
protective against pertussis infection in infants.20 Unfortunately, the majority of mothers in 
our study received the vaccine at least four weeks after delivery when there is less evidence of 
such benefit. Awareness of cocooning strategy is low in South Australia and this may relate to 
absence of funding for this progam. In 2011, all States in Australia, except South Australia 
and Tasmania, provided funding to subsidise the cost of the pertussis vaccine for new 
parents.
21
 When a recommended vaccine is not funded it may be perceived as less important 







































 In addition, whilst the majority of women who had not recently been immunized 
with pertussis vaccine intended to receive the pertussis vaccine postnatally, very few followed 
through with this intention. Previous studies have shown that intent does not necessarily 
correlate with uptake.
23
 Mothers indicated less concern about receiving pertussis 
immunization during pregnancy than other vaccines.  The primary reason given for not having 
received pertussis vaccine postnatally was that it had not been offered to them or discussed 
with them, or that mothers were not aware of the health benefits of immunization in this 
setting. These are all potentially significant barriers to immunization receipt. A small number 
of women were alerted to the recommendation through participation in this study suggesting 
receipt of minimal information has the potential to improve uptake.  
A recent study in the USA showed a high proportion (72%) of women received pertussis 
vaccine in the postpartum period when it was provided by the hospital before discharge. 
When women who had not been offered the vaccine were excluded from the analysis, 
however, uptake was 96.2%.24 In this study, some women indicated that they did not receive 
the immunization after pregnancy because they were too busy after their baby was born. If 
pertussis immunization were available to postpartum women before hospital discharge this 
would be likely to increase uptake. This may also explain why multiparous women were less 
likely to receive influenza vaccine. Alternatively multiparous women may have considered 
repeat influenza immunization unnecessary. These data suggest that multiparous pregnant 
women should be targeted in influenza vaccine campaigns. 
A limited proportion of mothers understood the importance or availability of pregnancy-
related immunisation. A number of studies indicate that recommendations from HCPs play a 
major role in parents’ decision making about vaccine acceptance.25-29 A large proportion of 
the women in this study did not receive pre-pregnancy immunization planning, thus making 
maternal and postpartum pertussis immunization recommendation by HCPs even more 





































An effective maternal immunization program is reliant upon confident communication 
between HCP and prospective parents about the benefits and risks of pregnancy related 
immunization to optimise protection for pregnant women and their newborns. It is imperative 
that information to assist in vaccine awareness and vaccination decision making in Australian 
women with a non-English speaking background becomes widely available. This will begin to 
address the barriers to vaccination which may benefit all women and their newborns. 
Materials and Methods 
Study design 
This cross-sectional observational study was undertaken between December 2010 and 
September 2011 at the Women’s and Children’s Hospital (WCH).  The WCH is the largest of 
three major public maternity hospitals in South Australia, providing maternity care for 
metropolitan Adelaide and is the primary tertiary maternity hospital for complex care with 
approximately 5,000 births per year. Both public and private patients with diverse ethnicity 
and socio-economic status attend this obstetric hospital and were approached for participation 
in this study at any gestational period. 
Interviews of pregnant women using a survey questionnaire 
A questionnaire directed interview was held with pregnant women, to identify whether 
prospective parents were following or intending to follow immunization recommendations for 
pregnant women or those planning a pregnancy. This questionnaire was developed to identify 
demographic and other factors associated with uptake of cocooning strategy and influenza 
vaccination based on previous literature and questionnaires developed and published by the 
research team.30 A mixture of yes/no response and open-ended questions were used.  A 
follow-up telephone call was made to participants eight to 10 weeks after the birth of their 





































the actual uptake of the recommended immunizations. A non-medical researcher asked the 
survey questions without any additional information being provided about the diseases under 
consideration, so as not to bias the participants’ decisions about receiving further 
vaccinations.  Information was collected at a follow-up call to ascertain reasons why mothers 
received any further immunizations and to identify whether participation in the study had 
influenced their decision. 
Participant recruitment 
Women attending the public and private antenatal clinics at the Women’s and Children’s 
Hospital (WCH) were provided with study information and invited to participate following 
informed consent until the desired sample size (n=297) was achieved.  Pregnant women were 
eligible to participate regardless of gestation or expected delivery date (peak influenza season 
or otherwise) with language barriers being the only exclusion criteria. The questionnaire was 
only available in English, although an Asian language interpreter was available Participants’ 
demographic characteristics, immunization history, awareness and knowledge of, and 
attitudes towards pregnancy-related immunization were recorded.   
Statistical analyses  
The sample size was estimated on the primary outcome: the expected proportion of mothers 
who had received a pertussis vaccine either within the previous five years or following 
delivery. An adult vaccination survey in 2009,31 estimated that 7.8% of South Australians 
received a pertussis vaccine as an adult. Using a sampling error of 0.03 (i.e. 3% above or 
below the expected estimate) a sample size of 297 was calculated.  
Multivariable analysis was used to identify factors independently associated with pertussis 
and influenza vaccine uptake. Predictors that had a global p value < 0.15 in univariate models 





































ratios with 95% confidence intervals. A two-tailed p-value of less than 0.05 was considered to 
be statistically significant. Statistical analyses were performed using Stata statistical software, 
Version 11, College station: Stata corporation 2010.
32 
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Table 1: Demographic characteristic of respondents at antenatal interviews (n=297) 
Variable Levels Number of individuals Percentage 
Age Group ≤ 20 years 16 5.4 
 21-30 138 46.5 
 31-40 132 44.4 
 >40 11 3.7 
Number of children at time 0 139 46.8 
 1 101 34.0 
 2 36 12.1 
 ≥3 21 7.1 
Marital Status Never married/Single 18 6.1 
 Married 183 61.6 
 Divorced/Separated 8 2.7 
 Living with a partner 88 29.6 
Work Status Full-time employed 93 31.4 
 Part-time/Casual 79 26.7 
 Self-employed 7 2.4 
 Unemployed/Home duties 101 34.1 
 Student 16 5.4 
Born in Australia Yes 219 73.7 
 No 78 26.3 
English first language Yes 247 83.2 
 No 50 16.8 
Race Caucasian 258 86.9 
 Aboriginal/Torres Strait 4 1.4 
 Asian 30 10.1 
 Other/mixed 5 1.7 
Area Metropolitan 245 82.5 
 Non-metropolitan 52 17.5 
Highest educational 
attainment 
Did not complete high 
school 
40 13.5 




 Bachelor or higher 111 37.4 
Household income <$20,000 13 4.4 
 $20,001-$40,000 19 6.4 
 $40,001-$80,000 88 29.6 
 >$80,001 83 28.0 





































Health care benefits  Yes (health care/pensioner 
concession card) 
87 29.4 
 None 209 70.6 
Had pregnancy planning Yes 67 22.6 






































Table 2: Predictors of receipt of pertussis vaccination within last 5 years or following birth 
Variable Level 
n Risk 




Risk ratio 95% CI 
P-      
value 
Age group ≤30 y 154 1.0   1.0   
>30y 143 1.60 1.03,2.46 0.034 1.22 0.81,1.83 0.332 
Area Metropolitan 245 1.0      
Regional 52 1.35 0.83,2.22 0.220    
English as first 
language 
Yes 247 1.0   1.0   
No 50 0.23 0.08,0.71 0.010 0.24 0.08,0.73 0.011 
Educational 
attainment 
Tertiary  197 1.0  (0.043) 1.0  (0.083) 
High school 60 0.68 0.38,1.22 0.196 0.66 0.38,1.16 0.149 
Did not complete 
high school 
40 0.28 0.09,0.85 0.024 0.33 0.10,1.05 0.061 
Number of 
children at home  
0 139 1.0  (0.604)    
1 101 1.19 0.75,1.89 0.451    
≥2 57 0.89 0.48,1.66 0.723    
Marital status Married 183 1.0  (0.321)    
Single/Separated/ 
Widowed 
26 0.62 0.25,1.60 0.326    
Living with a 
partner  
88 0.83 0.51,1.35 0.456    




117 0.67 0.42,1.06 0.09 0.93 0.61,1.41 0.731 
Health 
care/pensioner 
No  209 1.0      
Yes 87 1.17 0.75,1.83 0.478    
Pregnancy 
planning with GP 
No 230 1.0      
Yes 67 1.36 0.86,2.14 0.188    
HCP 
recommended 
No 241 1.0   1.0   
Yes 52 2.80 1.89,4.16 <0.001 2.07 1.37,3.14 0.001 
Aware of adult 
pertussis vaccine 
No 156 1.0   1.0   
Yes 74 2.16 1.42,3.30 <0.001 1.44 0.93,2.23 0.103 





































Only univariate associations with p value <0.15 were included in the multivariate regression 
model due to the small number of respondents reporting the outcome of pertussis vaccination 
















































ratio 95% CI 
P-  
value 
Age group ≤30 y 113 1.00      
>30y 124 0.74 0.43.1.18 0.186    
Area Metropolitan 193 1.00      
Regional 44 1.30 0.72,2.35 0.376    
English as first 
language 
Yes 199 1.00      




Degree or higher 95 1.00  (0.880)    
Trade/certificate/ 
diploma 
62 1.05 0.56,1.97 0.883    
High school 53 1.13 0.59,2.15 0.704    
Did not complete 
high school 




0 108 1.00  (0.027) 1.00  (0.015) 
1 82 0.61 0.35,1.08 0.092 0.58 0.34,1.00 0.045 
≥2 47 0.31 0.11,0.82 0.019 0.32 0.12, 0.83 0.017 
Marital status Married 152 1.00  (0.309)    
Single/Separated/ 
Widowed 
16 0.68 0.18,2.59 0.570    
Living with a 
partner  
69 1.42 0.84,2.38 0.189    








No 55 1.00      




No 177 1.00   1.00   





No 182 1.00   1.00   








































No 67 1.00   1.00   
Yes 170 4.33 1.62, 11.59 0.003 3.14 1.15,8.61 0.026 
Global p values are presented in brackets where applicable 
Only univariate associations with p value <0.15 were included in the multivariate regression 







































Table 4: Reasons why women did not receive any recommended vaccines in the postpartum 
period (n=230) 




Not offered or discussed/ not aware of need for  71 30.9 
Do not believe it is necessary to have vaccinations so soon after the 
birth 
41 17.8 
Time poor/ busy with the baby/ baby health issues 40 17.4 
Forgot to have them/haven't thought about it 31 13.5 
Already vaccinated for whooping cough 28 12.2 
Cost 6 2.6 
Accessibility / vaccine not available 6 2.6 
Do not believe in vaccinations/vaccines are ineffective  6 2.6 
Side effects of vaccines for myself 4 1.7 
Medical  4 1.7 
Doctor busy/ couldn't find anywhere close to home to get vaccines  3 1.3 
Side effects of vaccines on my baby (through breastfeeding) 1 0.4 





































Other  6 3.0 
Number does not equal 230 as multiple responses allowed. Other: no reason given (n=3), 







































Figure 1. Study population. 
465 Pregnant women were approached by research staff 
300 women were enrolled in the study 165 women declined to participate 
297 participants completed the questionnaire  
3 participants withdrew due to time 
constraints in completing the 
questionnaire 
25 participants withdrew  
Lost to follow up (n=22) 
Intrauterine death or stillbirth (n=3) 
272 participants were able to be contacted and 
completed the follow up questions at 8 weeks 
post delivery 
3 participants withdrew due to time 







































Figure 2: Concerns regarding recommended maternal vaccines 
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